Table of Contents 2
List of Tables 5
List of Figures 5
Ferring Intertiol Center S.A. Spshot 6
Ferring Intertiol Center S.A. Overview 6
Key Information 6
Key Facts 6
Ferring Intertiol Center S.A. - Research and Development Overview 7
Key Therapeutic Areas 7
Ferring Intertiol Center S.A. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combition Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combition Treatment Modalities 14
Ferring Intertiol Center S.A. - Pipeline Products Glance 15
Ferring Intertiol Center S.A. - Late Stage Pipeline Products 15
Pre-Registration Products/Combition Treatment Modalities 15
Phase III Products/Combition Treatment Modalities 16
Ferring Intertiol Center S.A. - Clinical Stage Pipeline Products 17
Phase II Products/Combition Treatment Modalities 17
Ferring Intertiol Center S.A. - Early Stage Pipeline Products 18
Preclinical Products/Combition Treatment Modalities 18
Ferring Intertiol Center S.A. - Drug Profiles 19
follitropin delta 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Testavan 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
degarelix acetate 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
elobixibat 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
selepressin 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
barusiban 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
carbetocin 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
FE-999301 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
merotocin 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
FE-201874 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
FE-204038 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
FE-999310 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule for Undisclosed Indication 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Ferring Intertiol Center S.A. - Pipeline Alysis 34
Ferring Intertiol Center S.A. - Pipeline Products by Target 34
Ferring Intertiol Center S.A. - Pipeline Products by Route of Administration 35
Ferring Intertiol Center S.A. - Pipeline Products by Molecule Type 36
Ferring Intertiol Center S.A. - Pipeline Products by Mechanism of Action 37
Ferring Intertiol Center S.A. - Recent Pipeline Updates 38
Ferring Intertiol Center S.A. - Dormant Projects 41
Ferring Intertiol Center S.A. - Discontinued Pipeline Products 42
Discontinued Pipeline Product Profiles 42
DR-2011 42
Ferring Intertiol Center S.A. - Locations and Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49